Tempus AI is accelerating foundation model development by utilizing digital slide archives from Memorial Sloan Kettering Cancer Center and Microsoft Azure.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tempus AI is accelerating foundation model development by utilizing digital slide archives from Memorial Sloan Kettering Cancer Center and Microsoft Azure.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Memorial Sloan Kettering Cancer Center
cancer treatment and research institution in New York City, United States
Nothing else this week.
-
Microsoft
American multinational technology corporation
-
Tempus
biotechnology company based in Chicago, Illinois
Related events
- OpenAI models are now available on Google Cloud, expanding the distribution of AI models across major cloud providers.
- Microsoft AI is testing its models with Meta and DeepSeek, joining Google and OpenAI in AI claims.
- Microsoft, Anthropic, and CrowdStrike are involved in a consortium called Project Glasswing, focusing on AI security and leveraging cloud platforms like Azure.
- Big Tech firms plan to invest over $700 billion in AI infrastructure, with healthcare identified as a key test case for AI returns.
- Major tech firms announce partnerships and massive investments to accelerate AI adoption, cloud expansion, and data center infrastructure.
Coverage
Newest first; wire copies grouped- MedTech DiveTempus inks $81M Paige buyout to support AI model development This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newslet